相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原:
Recombinant protein corresponding to SARS-CoV-2 Spike RBD.
- 亚型:
IgG
- 形态:
Liquid
- 保存条件:
Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4ºC. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles.
- 克隆性:
Monoclonal
- 标记物:
HRP
- 保质期:
12 months from the shipping date of the product.
- 抗原来源:
SARS Coronavirus 2
- 目录编号:
GTX635807-01
- 级别:
Primary Antibodies
- 库存:
Available
- 供应商:
GeneTex
- 宿主:
Rabbit
- 应用范围:
ELISA
- 浓度:
0.83 mg/ml (Please refer to the vial label for the specific concentration.)
- 抗体英文名:
SARS-CoV-2 (COVID-19) Spike RBD antibody [HL1014] (HRP)
- 抗体名:
SARS-CoV-2 (COVID-19) Spike RBD 抗体 [HL1014] (HRP)
- 规格:
50 μl
Sandwich ELISA detection of SARS-CoV-2 (COVID-19) Spike (ECD) Protein, Omicron / BA.2.75 variant, His tag (GTX137533-pro) using ELISA pairs below.
Pair 1:
Capture: SARS-CoV-2 (COVID-19) Spike RBD antibody [HL1003] (GTX635792) (5 μg/mL)
Detection: SARS-CoV-2 (COVID-19) Spike RBD antibody [HL1014] (HRP) (GTX635807-01) (1 μg/mL)
Pair 2:
Capture: SARS-CoV-2 (COVID-19) Spike RBD antibody [HL1004] (GTX635793) (5 μg/mL)
Detection: SARS-CoV-2 (COVID-19) Spike RBD antibody [HL1014] (HRP) (GTX635807-01) (1 μg/mL)
Pair 3:
Capture: SARS-CoV-2 (COVID-19) Spike RBD Omicron antibody [HL1866] (GTX637591) (5 μg/mL)
Detection: SARS-CoV-2 (COVID-19) Spike RBD antibody [HL1014] (HRP) (GTX635807-01) (1 μg/mL)
Sandwich ELISA detection of SARS-CoV-2 (COVID-19) Spike (ECD) Protein, Omicron / BA.2.75 variant, His tag (GTX137533-pro) using ELISA pairs below.
Pair 1:
Capture: SARS-CoV-2 (COVID-19) Spike RBD Omicron antibody [HL1867] (GTX637592) (5 μg/mL)
Detection: SARS-CoV-2 (COVID-19) Spike RBD antibody [HL1014] (HRP) (GTX635807-01) (1 μg/mL)
Pair 2:
Capture: SARS-CoV-2 (COVID-19) Spike RBD antibody [HL1014] (GTX635807) (5 μg/mL)
Detection: SARS-CoV-2 (COVID-19) Spike RBD antibody [HL1004] (HRP) (GTX635793-01) (1 μg/mL)
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验中科院高福院士课题组 2020 年发表了哪些重要的研究成果?
:Science 9、Science 后再发 Nature!筛选出又一新冠病毒治疗性单克隆中和抗体DOI: 10.1038/s41586-020-2381-y继之前发表在 Science 上报道筛选出新冠病毒中和抗体后,2020 年 5 月 26 日,高福院士再次联合严景华等人在 Nature 发文:A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2。该研究报告了从 COVID-19 恢复期的患者中分离出两
neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability. Preprint at bioRxiv 11: Lynch, KL et al. (2020) Magnitude and kinetics of anti-SARS-CoV-2 antibody responses and their relationship to disease severity. Preprint
日前,北京大学生命科学学院魏文胜课题组在 Cell 杂志上在线发表题为“Circular RNA Vaccines against SARS-CoV-2 and Emerging Variants”的研究论文。 魏文胜团队首先建立了体外高效制备高纯度环状 RNA 的技术平台,针对新型冠状病毒及其变异株,设计了编码新冠病毒刺突蛋白(Spike)受体结构域(RBD)的环状 RNA 疫苗。 该项研究中制备的针对新冠病毒德尔塔变异株的环状 RNA 疫苗(circRNARBD
技术资料暂无技术资料 索取技术资料







![p53 (phospho Ser46) antibody [#36]](https://img1.dxycdn.com/2022/0328/364/1372708775817700453-14.jpg!wh200)


